Imaging in drug development: will it deliver on the promise of personalised medicine?

Br J Radiol

Oncology Clinical Imaging Group, Translational Medicine, Novartis Pharmaceuticals Corporation, Inc, 180 Park Avenue, Florham Park, NJ 07932, USA.

Published: June 2010

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473602PMC
http://dx.doi.org/10.1259/bjr/65491666DOI Listing

Publication Analysis

Top Keywords

imaging drug
4
drug development
4
development will
4
will deliver
4
deliver promise
4
promise personalised
4
personalised medicine?
4
imaging
1
development
1
will
1

Similar Publications

Preliminary Evidence for Perturbation-Based tACS-EEG Biomarkers of Gamma Activity in Alzheimer's Disease.

Int J Geriatr Psychiatry

January 2025

Precision Neuroscience & Neuromodulation Program, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Background: Alzheimer's disease (AD) is characterized by impaired inhibitory circuitry and GABAergic dysfunction, which is associated with reduced fast brain oscillations in the gamma band (γ, 30-90 Hz) in several animal models. Investigating such activity in human patients could lead to the identification of novel biomarkers of diagnostic and prognostic value. The current study aimed to test a multimodal "Perturbation-based" transcranial Alternating Current Stimulation-Electroencephalography (tACS)-EEG protocol to detect how responses to tACS in AD patients correlate with patients' clinical phenotype.

View Article and Find Full Text PDF

[A Review of progresses in research on delayed resistance to EGFR-TKI by Traditional Chinese medicine via inhibiting cancer stem cells properties].

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

January 2025

Department of Integrated Traditional Chinese and Western Medicine, Shandong First Medical University Affiliated Cancer Hospital, Jinan 250117, China. *Corresponding author, E-mail:

It has been popular and challenging to undertake researches on the delay of acquired resistance of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). As key cells for tumor initiation, cancer stem cells (CSC) play an important role in the process of resistance to EGFR-TKI. Although preliminary studies found that traditional Chinese medicine (TCM) could inhibit CSC properties and delay EGFR-TKI resistance, the specific molecular mechanism remains unclear.

View Article and Find Full Text PDF

Diagnosis and treatment of pediatric arterial stenosis associated with neurofibromatosis type 1.

BMC Pediatr

January 2025

Department of Orthopedics, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No.56, Nanlishi Road, Beijing, 100045, China.

Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder affecting multiple systems. However, arterial stenosis is a rare manifestation in patients with NF1. Since the symptoms of arterial stenosis caused by NF1 are often atypical and have a high under-diagnosis rate, this can lead to serious complications such as hypertension, ischemic stroke, or even death.

View Article and Find Full Text PDF
Article Synopsis
  • Depression treatment effectiveness differs greatly among individuals, highlighting the need for objective biomarkers that can accurately predict therapy outcomes to improve treatment efficiency.
  • This study used functional near-infrared spectroscopy (fNIRS) combined with clinical assessments to explore whether machine learning techniques could forecast treatment responses in patients with major depressive disorder (MDD).
  • Findings revealed that changes in total hemoglobin levels in a specific brain region (dlPFC) correlated significantly with treatment response, and the fNIRS-only model demonstrated better predictive accuracy compared to a model that also included clinical data.
View Article and Find Full Text PDF

Advancement in synthetic gene circuits engineering: An alternative strategy for microRNA imaging and disease theranostics.

Biotechnol Adv

January 2025

Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China; Institute of Medical Engineering, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, China; Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy, Shaanxi University of International Trade & Commerce, Xianyang 712046, China. Electronic address:

Gene circuits, which are genetically engineered systems designed to regulate gene expression, are emerging as powerful tools in disease theranostics, especially in mammalian cells. This review explores the latest advances in the design and application of gene circuits for detecting and treating various diseases. Synthetic gene circuits, inspired by electronic systems, offer precise control over therapeutic gene activity, allowing for real-time, user-defined responses to pathological signals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!